107 related articles for article (PubMed ID: 27734272)
1. Distinct expression profile of key molecules in crawling-type early gastric carcinoma.
Woo HY; Bae YS; Kim JH; Lee SK; Lee YC; Cheong JH; Noh SH; Kim H
Gastric Cancer; 2017 Jul; 20(4):612-619. PubMed ID: 27734272
[TBL] [Abstract][Full Text] [Related]
2. Analysis of clinicopathological and molecular features of crawling-type gastric adenocarcinoma.
Fujita Y; Uesugi N; Sugimoto R; Eizuka M; Toya Y; Akasaka R; Matsumoto T; Sugai T
Diagn Pathol; 2020 Sep; 15(1):111. PubMed ID: 32943104
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive expression profiles of gastric cancer molecular subtypes by immunohistochemistry: implications for individualized therapy.
Kim HS; Shin SJ; Beom SH; Jung M; Choi YY; Son T; Kim HI; Cheong JH; Hyung WJ; Noh SH; Chung H; Park JC; Shin SK; Lee SK; Lee YC; Koom WS; Lim JS; Chung HC; Rha SY; Kim H
Oncotarget; 2016 Jul; 7(28):44608-44620. PubMed ID: 27331626
[TBL] [Abstract][Full Text] [Related]
4. Receptor tyrosine kinase amplified gastric cancer: Clinicopathologic characteristics and proposed screening algorithm.
Park CK; Park JS; Kim HS; Rha SY; Hyung WJ; Cheong JH; Noh SH; Lee SK; Lee YC; Huh YM; Kim H
Oncotarget; 2016 Nov; 7(44):72099-72112. PubMed ID: 27765925
[TBL] [Abstract][Full Text] [Related]
5. "Crawling-type" adenocarcinoma of the stomach: a distinct entity preceding poorly differentiated adenocarcinoma.
Okamoto N; Kawachi H; Yoshida T; Kitagaki K; Sekine M; Kojima K; Kawano T; Eishi Y
Gastric Cancer; 2013 Apr; 16(2):220-32. PubMed ID: 22865191
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological features of programmed death ligand 1 expression with tumor-infiltrating lymphocyte, mismatch repair, and Epstein-Barr virus status in a large cohort of gastric cancer patients.
Kawazoe A; Kuwata T; Kuboki Y; Shitara K; Nagatsuma AK; Aizawa M; Yoshino T; Doi T; Ohtsu A; Ochiai A
Gastric Cancer; 2017 May; 20(3):407-415. PubMed ID: 27629881
[TBL] [Abstract][Full Text] [Related]
7. ARID1A expression in gastric adenocarcinoma: clinicopathological significance and correlation with DNA mismatch repair status.
Inada R; Sekine S; Taniguchi H; Tsuda H; Katai H; Fujiwara T; Kushima R
World J Gastroenterol; 2015 Feb; 21(7):2159-68. PubMed ID: 25717252
[TBL] [Abstract][Full Text] [Related]
8. A case of gastric cancer with heterogeneous components of EB virus (+)/TP53 (+) and EB virus (-)/TP53 (-).
Matsuda I; Kan K; Doi S; Motoki Y; Onodera M; Hirota S
Int J Clin Exp Pathol; 2015; 8(9):11766-71. PubMed ID: 26617924
[TBL] [Abstract][Full Text] [Related]
9. Down regulation of gastric and intestinal phenotypic expression in Epstein-Barr virus-associated stomach cancers.
Hirano N; Tsukamoto T; Mizoshita T; Koriyama C; Akiba S; Campos F; Carrasquilla G; Carrascal E; Cao X; Toyoda T; Ban H; Miki K; Tatematsu M
Histol Histopathol; 2007 Jun; 22(6):641-9. PubMed ID: 17357094
[TBL] [Abstract][Full Text] [Related]
10. A Detailed Immunohistochemical Analysis of a Large Series of Cervical and Vaginal Gastric-type Adenocarcinomas.
Carleton C; Hoang L; Sah S; Kiyokawa T; Karamurzin YS; Talia KL; Park KJ; McCluggage WG
Am J Surg Pathol; 2016 May; 40(5):636-44. PubMed ID: 26685087
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemistry as a surrogate for molecular subtyping of gastric adenocarcinoma.
Gonzalez RS; Messing S; Tu X; McMahon LA; Whitney-Miller CL
Hum Pathol; 2016 Oct; 56():16-21. PubMed ID: 27342907
[TBL] [Abstract][Full Text] [Related]
12. Gastric cancer: immunohistochemical classification of molecular subtypes and their association with clinicopathological characteristics.
Birkman EM; Mansuri N; Kurki S; Ålgars A; Lintunen M; Ristamäki R; Sundström J; Carpén O
Virchows Arch; 2018 Mar; 472(3):369-382. PubMed ID: 29046940
[TBL] [Abstract][Full Text] [Related]
13. Gastric cancer and concomitant renal cancer: a systematic immunohistochemical and molecular analysis.
Betge J; Pollheimer MJ; Schlemmer A; Hoefler G; Langner C
Oncol Rep; 2011 Sep; 26(3):567-75. PubMed ID: 21687951
[TBL] [Abstract][Full Text] [Related]
14. Importance of universal mismatch repair protein immunohistochemistry in patients with sebaceous neoplasia as an initial screening tool for Muir-Torre syndrome.
Jessup CJ; Redston M; Tilton E; Reimann JD
Hum Pathol; 2016 Mar; 49():1-9. PubMed ID: 26826402
[TBL] [Abstract][Full Text] [Related]
15. [Expression of MMR in endometrial adenocarcinoma in women under 50 years old].
Wu HX; Song JC; Shi YQ; Liu YX
Zhonghua Bing Li Xue Za Zhi; 2012 Nov; 41(11):733-6. PubMed ID: 23302332
[TBL] [Abstract][Full Text] [Related]
16. MET overexpression, gene amplification and relevant clinicopathological features in gastric adenocarcinoma.
Zhang J; Guo L; Liu X; Li W; Ying J
Oncotarget; 2017 Feb; 8(6):10264-10273. PubMed ID: 28052014
[TBL] [Abstract][Full Text] [Related]
17. Mucin phenotype and background mucosa of intramucosal differentiated-type adenocarcinoma of the stomach.
Sasaki A; Kitadai Y; Ito M; Tanaka S; Yoshihara M; Haruma K; Chayama K
Oncology; 2004; 66(5):379-87. PubMed ID: 15331925
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathologic characteristics of Epstein-Barr virus-incorporated gastric cancers in Korea.
Chang MS; Lee HS; Kim CW; Kim YI; Kim WH
Pathol Res Pract; 2001; 197(6):395-400. PubMed ID: 11432666
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemistry for PMS2 and MSH6 alone can replace a four antibody panel for mismatch repair deficiency screening in colorectal adenocarcinoma.
Hall G; Clarkson A; Shi A; Langford E; Leung H; Eckstein RP; Gill AJ
Pathology; 2010; 42(5):409-13. PubMed ID: 20632815
[TBL] [Abstract][Full Text] [Related]
20. High-throughput Protein and mRNA Expression-based Classification of Gastric Cancers Can Identify Clinically Distinct Subtypes, Concordant With Recent Molecular Classifications.
Ahn S; Lee SJ; Kim Y; Kim A; Shin N; Choi KU; Lee CH; Huh GY; Kim KM; Setia N; Lauwers GY; Park DY
Am J Surg Pathol; 2017 Jan; 41(1):106-115. PubMed ID: 27819872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]